chrisvoncsefalvay/vaers-outcomes huggingface dataset:
- Difficulty breathing, - Tachycardia, - Chills 3 hrs post vaccination lasting approx 20 hrs. Missed 1 day of work. Took BENADRYL. Sx. subsided. Did not seek medical attention.
Vasovagal reaction, patient was sitting and fainted shortly after receiving vaccine. Did not eat much before vaccine. He immediately knew his name, where he was, etc.
Vax given.15 minutes later, child complained of feeling hot, having a headache, & having a syncopal episode.No LOC, & no obvious injury.
My genitals have developed a rash; Itchy response in 24 hours after receiving my covid booster injection.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 17Oct2021 10:00 (Lot number: FF2593) at the age of 39 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Known allergies: All cillins" (unspecified if ongoing), notes: Known allergies: All cillins; "Known allergies: Bee stings" (unspecified if ongoing), notes: Known allergies: Bee stings; "Known allergies: Latex" (unspecified if ongoing), notes: Known allergies: Latex; "Known allergies: Seafood" (unspecified if ongoing), notes: Known allergies: Seafood. Concomitant medication(s) included: ALPRAZOLAM; PROPRANOLOL; ESCITALOPRAM; SEQIRUS FLUCELVAX QUAD PF, administration date 06Oct2021. Vaccination history included: Bnt162b2 (Prev dose Product: COVID 19, Prev dose Brand: Pfizer, Prev dose Lot number: ER8727, Prev dose Vaccine location: Right arm, Prev dose Dose number: 1), administration date: 21Mar2021, when the patient was 38 years old, for COVID-19 Immunization; Bnt162b2 (Prev dose Product: COVID 19, Prev dose Brand: Pfizer, Prev dose Lot number: EW0153, Prev dose Vaccine location: Right arm, Prev dose Dose number: 2), administration date: 11Apr2021, when the patient was 38 years old, for COVID-19 Immunization.  The following information was reported: GENITAL RASH (non-serious) with onset 17Oct2021, outcome "recovering", described as "My genitals have developed a rash"; PRURITUS GENITAL (non-serious) with onset 17Oct2021, outcome "recovering", described as "Itchy response in 24 hours after receiving my covid booster injection.". Therapeutic measures were not taken as a result of genital rash, pruritus genital. It was reported that prior to vaccination and since the vaccination patient was not diagnosed with Covid 19.  No follow-up attempts are possible. No further information is expected.
A 78-year-old female, who is currently intubated and sedated and unable to give any history. History is taken from the patient's daughter and husband, who are present. The patient has been involved in medical missionary work for years.  She was assisting at a small hospital in a remote area. Per the husband, she began feeling poorly in general on January 25 with malaise, fatigue, sore throat. On January 26, she was found to be unresponsive with a fever of 104. At the remote hospital, they apparently do surgeries with spinal anesthesia, so they used a spinal kit to do a lumbar puncture on her. They felt like the fluid visually appeared cloudy, and they tested it with a glucose test strip designed for blood. It registered as low, so they deduced that the CSF glucose level was low and together with cloudiness started treating her for meningitis with meropenem, vancomycin, acyclovir, ampicillin, ceftriaxone, and dexamethasone. They also felt that her mental status was slightly better after the LP, and they thought maybe she had high-pressure based on that. In the initial test of her blood, it was felt to be positive for malaria. Therefore, she was treated with quinine for 4 days. They were able to transfer her to the hospital in the city a couple of days after that. Her mental status was getting somewhat better, but she was still not having intelligible language, although she was obeying some commands. Then had her airlifted to alternate hospital on January 27. She was in the intensive care unit there and was intubated prior to her transfer there mainly as a precaution, not because she had any significant hypoxemia. On January 24, she was diagnosed with COVID-19 and a CT showed some typical pulmonary infiltrates. They continued with her antibiotic treatment, although she stopped dexamethasone after 4 days total. The patient's daughter works here and they made arrangements to transfer her here and she has arrived this evening on a ventilator. She is mildly hypothermic and was placed on a Bair Hugger on arrival. She was sent here on a Levophed drip, although I cannot find any documented hypotension. PATIENT REMAINS INPATIENT AT THIS TIME.
high fever, red swollen arm lasting 24-48 hrs. treated with Amoxicillin and Ibuprofen
Information has been received from a consumer concerning her 10 year old daughter with a history of severe allergies who on 01-FEB-2008 was vaccinated with pneumococcal 23v polysaccharide vaccine. Concomitant therapy included montelukast sodium (MSD), (dose, duration and indication not reported). Other concomitant therapy included fexofenadine hydrochloride and fluticasone furoate (VERAMYST). On 03-FEB-2008 the patient experienced pain in spine, neck, shoulder and knee. She received pneumococcal 23v polysaccharide vaccine to help with her chronic sinus problems. She has many allergies, but none to medications. The patient's pain in spine, neck, shoulder and knee persisted. She sought unspecified medical attention with the physician. Unspecified blood work was performed. Additional information has been requested. Changed Singular to a concomitant therapy instead of secondary suspect and added (MSD) to montelukast sodium in the narrative.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patients' concurrent condition and medical history were not provided. On 28-MAR-2016 the patient was vaccinated with improperly stored (Merck) VARIVAX (lot # L019125, exp.: 27-MAY-2017) (dose, route and site of administration not reported). Concomitant medication was not mentioned. The vaccine was stored at 12F for a time frame of 20 minutes daily for 140 days (incorrect product storage). The call was a result of a data logger. There was no previous temperature excursion reported. No adverse effects reported. No further information was provided. Product quality complaint was not filed. Additional information has been requested. This is one of the four reports received from the same reporter.
Dizziness, Headache, Fever, CHILLS, DROWSINESS, WEAKNESS, LIGHTHEADEDNESS Narrative:
Bruise; Dizziness; This is a spontaneous report from a contactable consumer (patient).     A 84-year-old female patient received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6201) via an unspecified route of administration, administered in arm right on 24Feb2021 (at the age of 84 years old) as dose 2, single for COVID-19 immunisation. Medical history included, sickness, and believed they had COVID virus, but they were told they had flu. Concomitant medication was not reported. It was reported that the patient takes heart pills and blood pressure pill (two pills a day). The patient previously received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: FL9261) on 26Jan2021 (at the age of 84 years old) as dose 1, single for COVID-19 immunisation. On 24Feb2021, the patient experienced dizziness. On an unspecified date, the patient experienced bruise. There were no prior vaccinations within 4 weeks. The outcome of the dizziness was recovered; outcome for the bruise was unknown.  No follow-up attempts are possible. No further information is expected.
0710 January 19th I received the second does of the Covid -19 vaccine. The site was very sore all day.  Around 2230 that night, I started having intermitted sharp pain in my leg arm pit. 0430 January 20th I woke up with sharp pains still in my left arm pit. By 1030 the pain was now constant and extreme.  I called my doctor and he told me to come into the office to see him. NP saw me and explained that the lymph nodes in my left arm were swollen. Very tender to touch also. He prescribed me Prednisone twice a day for three days, Ibuprofen, and use hot compresses. So far the pain has gotten better.
Pains in my shoulder at the injection site; Causing discomfort when trying to move my shoulder; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date Oct2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), administration date: 2021, for COVID-19 Immunization. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset Oct2021, outcome "not recovered", described as "Pains in my shoulder at the injection site"; MUSCULOSKELETAL DISCOMFORT (non-serious) with onset Oct2021, outcome "not recovered", described as "Causing discomfort when trying to move my shoulder".  Additional information: Forwarded as an Adverse Event by the team on 11Nov2021. Reporter provided verification of contact address on 10Nov2021. I received my second dose about a month ago. I was still having pains in my shoulder at the injection site causing discomfort when trying to move my shoulder.  Follow-up attempts are completed. No further information is expected.
Shortness of breath one week after second shot.  Still have that.  My resting heart rate is 80 and it is more typically around 60.
Initial report received from a nurse on 30 Nov 2010 and forwarded by Genentech (MCN: 310613) on 29 Dec 2010: This polymedicated patient with a current condition of hypertension, received influenza virus vaccine (manufacturer unknown, batch number unknown), subcutaneously on 17 Oct 2010. The patient was also started receiving XOLAIR, unknown dosage, subcutaneously for allergic asthma from 18 Oct 2010. On 10 Nov 2010, the patient experienced flu, and fungal infection. The blood test revealed a very high white blood cell count (values not provided). No seriousness criterion was provided. The action taken with XOLAIR, the event outcome and causality were not reported.
I am experiencing unusual muscle pain, tiredness, shivering, slight nausea 24 hours after receiving my 2nd Shingles Vaccine - Recombinant Zoster
Allergic to the Pertussis part; This case was reported by a consumer via interactive digital media and described the occurrence of allergic reaction in a adult patient who received DTP (A or W not known) (DTP vaccine) for prophylaxis.   On an unknown date, the patient received DTP vaccine at an unknown dose. On an unknown date, unknown after receiving DTP vaccine, the patient experienced allergic reaction (serious criteria hospitalization and life threatening). On an unknown date, the outcome of the allergic reaction was unknown.   It was unknown if the reporter considered the allergic reaction to be related to DTP vaccine.  Additional information was received as follows: The age at vaccination was not reported. The patient took the DPT shot when during childhood. The patient was allergic to the Pertussis part of it and it almost killed the patient and was in the hospital for a long time. The patient enquired whether there were any alternatives. The patient the hospital for a long time.
Got small rash on left side of abdomen; Was tested for antibodies to varicella/shingles.Received call 4/19/21 for highy elevated antibodies probably being shingles.; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 12Apr2021 at 11:00 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome and varicella. Concomitant medications included norethisterone (ERRIN) and ibuprofen (MANUFACTURER UNKNOWN). The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the arm left on 22Mar2021 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 08:00, the patient got small rash on left side of abdomen. Went to the clinic on 18Apr2021 for advice on what to use on it. The patient had a history of varicella as a child but no known stress or unusual circumstances that would trigger a reaction and no history of shingles previously. The patient was tested for antibodies to varicella/shingles and was diagnosed with highly elevated antibodies probably being shingles on 19Apr2021. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of small rash on left side of abdomen and highly elevated antibodies probably being shingles which included treatment with Medrol (Pak). The clinical outcome of the event small rash on left side of abdomen and highly elevated antibodies probably being shingles was resolving at the time of this report  No follow-up attempts are needed. No further information is expected.
This spontaneous report has been received from a nurse practitioner regarding a patient of unknown age or gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated VARIVAX dose 1 (dose, lot # and expiry date unknown). On 21-OCT-2009, patient received improperly stored VARIVAX dose 2, from lot # 664468/0684Y expiry date 15-MAY-2011. No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of several reports received from the same reporter. Additional information has been requested.
Mother reported that patient had some nausea and vomiting after second dose of vaccine but did not report it to the HD. After thirs dose, patient had nausea, vomiting, fever and chills. Mother called PCP and was told that it was possible vaccine reaction. Mother also called the hospital ER and spoke with a nurse last night regarding the reaction. Mother also reported that patient said she experienced some difficulty swallowing. Mother said that ER nurse told parent to administer Ibuprofen 800 mg. for fever.
I got a cold sore on my lip. I was prescribed valtrex and the cold sore cleared up.
A non-serious spontaneous report of "flu like" symptoms including muscle aches, tiredness and rash has been received from a consumer concerning a 14-year-old female, subsequent to receiving FluMist. No medical history nor drug history was reported.  The child received FluMist nasally on 10-Oct-2007.  The patient's father reported that several weeks after receiving FluMist the patient experienced "flu-like" symptoms including muscle aches, tiredness and a sporadic rash on the face every once in awhile. The patient's pediatric office, however, stated they have not seen the patient, nor were they notified in reference to a reaction with FLUMIST. The outcome is unknown. The events have not resolved; the child continues to experience these symptoms. Follow-up received on 12-Mar-2008: includes patient demographics and FLUMIST dosing information.
Fever, chills, headache, terrible body aches - took tylenol and Ibuprofen around the clock. very tired and sluggish for 2 days after vaccine .
Intense shoulder pain on the outside of the arm, in the area of the deltoid.  Inability to move arm.  A decrease in the range of motion within that left arm.  Feeling some achiness in the left elbow from this.  Also, a general weakness in the arm.  Also, experiencing the inability to move arm above the head.  More pain when laying down for bed.  Have tried ice, heat, antibotics and have been prescribed a steroid.  This has been three weeks so far.  Scheduled for a MRI of the left shoulder to see what is going on.  So far trying to keep the arm to my side and not extend it at times due to the pain.  Also, no previous shoulder problems before this and I have had the flu shot before.  It seemed as though it was placed futher back in the arm.  I am a female at 5 4"  and weight around 132lbs.
2/22/21 - achy/weak, nausea/vomiting with clear vomit taste like blood, no fever 2/23/21 to 2/25/21 - continues with weakness and developed joint pain and red rash on arm that had injection - rash lasted 4 days 3/12/21 - developed pain behind left knee and down to left foot 3/15/21 - knee/leg pain contiues and goes to urgent care - diagnosed with DVT 3/22/21 - developed chest pain, goes to ER, diagnosed with kidney stones
achy arm; body aches; This is a spontaneous report from a non-contactable consumer. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, it was reported that the patient had an achy arm and body aches for 12 hours after receiving his second dose of the vaccine. No other details other than he was fine after 12 hours was reported. It was unknown if the patient received treatment for the events. It was unknown if the patient was diagnosed with COVID-19 prior to vaccination or tested for COVID-19 post vaccination. On an unspecified date, the outcome of events was recovered.  No follow up attempts are possible. Information on the lot/batch number has been requested. No further information is expected.
A week post Covid shot, A hard lump appeared at injection site. It is Red, Hot, Itchy, 2.5 inx2.5in circumference.
swelled twice the original size; aching for 2 weeks following the first shot; redness for 2 weeks following the first shot; This case was reported by a pharmacist via call center representative and described the occurrence of swelling arm in a 53-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced swelling arm, pain and erythema. On an unknown date, the outcome of the swelling arm was unknown and the outcome of the pain and erythema were recovered/resolved.   It was unknown if the reporter considered the swelling arm, pain and erythema to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported, but it could be 52 or 53 years old. The patient received 1st dose of Shingrix. The patient expereinced adverse reactions such as the patient's arm swelled twice the original size, the patient also experienced aching and redness for 2 weeks. The reporter wanted to know, should patient receive the second dose. The reporter did not consent to follow up.
Patient received flu vaccine. After waiting a few minutes patient was helped with putting sweater and leather coat back on. Patient was walked out to wife in waiting room a few minutes later patient said shoe traction stuck on carpet making him fall and hit head on wall. Patient was helped up by staff, put in a wheelchair and was examined by provider in office. Ice pack was given to patient to apply to swelling on eye (right) and bandage placed on left hand where there was a small skin tear. Vital signs were taken and patient was released to home with spouse.
Patient received the first dose of the Pfizer COVID-19 vaccine. After administration, patient had a seat to be monitored for 15 minutes. After about 5 minutes patient started to feel light headed and was dropping his paperwork. Patient reports feeling dizzy and having arm numbness. Patient is seen to be sweating profoundly on the forehead and nose. Patient reports ingesting an edible prior to vaccine & mother reports patient does have anxiety. Pharmacy grad Intern took his blood pressure and BP was low at 67/33. Gave patient a cold water to help cool patient down and had him take deep slow breaths. Due to hypotensive state, 911 was called and EMT arrived to check patient vitals. After roughly 30 minutes patient seemed to be doing better and vitals were back to normal. Patient refused going to the hospital.  EMT walked patient to his mother's car and went home. Pharmacy took mother's phone number in order to follow up the next day to ensure patient is doing well.
booster shot; wheezy to her stomach; really dizzy; not feeling well; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (134184). The reporter is the patient.  A 64 year-old female patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTUERER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 2; MANUFACTUERER UNKNOWN), for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 2021, outcome "unknown", described as "booster shot"; WHEEZING (non-serious) with onset 2021, outcome "unknown", described as "wheezy to her stomach"; DIZZINESS (non-serious) with onset 2021, outcome "unknown", described as "really dizzy"; MALAISE (non-serious) with onset 2021, outcome "unknown", described as "not feeling well". The lot number for bnt162b2 was not provided and will be requested during follow up.
Diagnosed with PMR Poly Mialga Rhumatica  Severe shoulder, arm, wrist, knee,thigh,neck hips and back pain
PT SAID HE EXPERIENCE BAD NEUROPATHY ABOUT A WEEK BEFORE GETTING THE SECOND SHOT. HE CHECKED HIS A1C AND WAS 9.7. HE GOT THE SECOND SHOT AND EXPERIENCED EXRTREME MUSCLE FATIGUE AND EXTREME CRAMPING. HIS SON WAS TOO SCARED TO LEAVE HIM ALONE AT HIS HOUSE AFTER THEIR FISHING TRIP
she was sick for about 5 days a few weeks ago.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): EC-2021-102695.  A female patient received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) intramuscular for covid-19 immunisation; lenvatinib mesilate (LENVIMA), since 28Oct2021 (Batch/Lot number: unknown) at 12 mg. The patient's relevant medical history included: "C22 Liver Cancer" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete;  unknown manufacturer), for COVID-19 immunization. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "she was sick for about 5 days a few weeks ago.". The action taken for lenvatinib mesilate was unknown.  Additional information: Patient advised she was sick for about 5 days a few weeks ago. Her illness coincided with getting her COVID booster shot. She believe this issue was caused by the COVID booster shot and not Lenvima. PI reviewed.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.